InvestSMART

Clarity Pharmaceuticals Ltd (ASX: CU6) - Announcements

Current share price for CU6 : $2.280 0.01 (0.44%)+

ASX company news and announcements for Clarity Pharmaceuticals Ltd (CU6) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clarity Pharmaceuticals Ltd (CU6) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clarity Pharmaceuticals Ltd (CU6), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clarity Pharmaceuticals Ltd (CU6)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$851 Co-PSMA abstract released 16 Feb 2026 9:42AM $2.860 $2.280 fallen by 20.28%
$851 Change in substantial holding 12 Feb 2026 5:27PM $3.030 $2.280 fallen by 24.75%
$851 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2026 10:50AM $3.160 $2.280 fallen by 27.85%
$851 SECuRE trial to continue with no modifications to protocol 15 Jan 2026 9:46AM $3.600 $2.280 fallen by 36.67%
$851 Notification of cessation of securities - CU6 7 Jan 2026 4:45PM $3.920 $2.280 fallen by 41.84%
$851 Co-PSMA abstract accepted for oral presentation at EAU 24 Dec 2025 10:02AM $3.190 $2.280 fallen by 28.53%
$851 Positive guidance from the US FDA on Cu-64 SARTATE Phase III 22 Dec 2025 9:19AM $3.340 $2.280 fallen by 31.74%
$851 Clarity to present DISCO trial data at ASCO-GI 2026 9 Dec 2025 9:56AM $2.950 $2.280 fallen by 22.71%
$851 Notification regarding unquoted securities - CU6 8 Dec 2025 12:24PM $2.990 $2.280 fallen by 23.75%
$851 Notification regarding unquoted securities - CU6 2 Dec 2025 2:37PM $3.320 $2.280 fallen by 31.33%
$851 Ceasing to be a substantial holder 1 Dec 2025 8:14AM $3.610 $2.280 fallen by 36.84%
$851 Change of Director's Interest Notice - M Parker 28 Nov 2025 4:59PM $3.610 $2.280 fallen by 36.84%
$851 Change of Director's Interest Notice - C Biggin 28 Nov 2025 4:57PM $3.610 $2.280 fallen by 36.84%
$851 Change of Director's Interest Notice - A Taylor 28 Nov 2025 4:54PM $3.610 $2.280 fallen by 36.84%
$851 Becoming a substantial holder 27 Nov 2025 8:22AM $3.610 $2.280 fallen by 36.84%
$851 Results of Meeting 25 Nov 2025 12:16PM $3.435 $2.280 fallen by 33.62%
$851 Chairperson Address AGM 25 Nov 2025 9:50AM $3.640 $2.280 fallen by 37.36%
$851 AGM MD Presentation 25 Nov 2025 9:29AM $3.640 $2.280 fallen by 37.36%
$851 Ceasing to be a substantial holder 24 Nov 2025 8:16AM $3.580 $2.280 fallen by 36.31%
$851 Becoming a substantial holder 14 Nov 2025 8:21AM $4.060 $2.280 fallen by 43.84%
$851 Cleansing Notice 11 Nov 2025 10:01AM $4.630 $2.280 fallen by 50.76%
$851 Application for quotation of securities - CU6 11 Nov 2025 9:58AM $4.620 $2.280 fallen by 50.65%
$851 Ceasing to be a substantial holder 7 Nov 2025 8:23AM $4.480 $2.280 fallen by 49.11%
$851 Change in substantial holding 5 Nov 2025 8:24AM $4.840 $2.280 fallen by 52.89%
$851 Change in substantial holding 4 Nov 2025 5:06PM $4.840 $2.280 fallen by 52.89%

51 - 75 of 511 results

Page 3 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.